← Browse by Condition
Medical Condition
high risk prostate cancer
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT05406999 Phase 2
Recruiting
Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer
Enrollment
900 pts
Location
China
Sponsor
The Affiliated Nanjing Drum To...
NCT06949254
Recruiting
PRospective Observational Study of STereotactic Body rAdiation Therapy With Androgen Deprivation Therapy for Organ-confined High-risk Prostate Cancer: the PROSTAR Trial
Enrollment
49 pts
Location
Italy
Sponsor
Istituto Clinico Humanitas